BridgeBio Pharma Inc
BBIO
Market Cap$6.27B
Close$
$-9.00
127.3% downside
Current Fair Value
127.3% downsideOvervalued by 127.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.27 Billion |
|---|---|
| Enterprise Value | $5.62 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.88 |
| Beta | 1.07 |
| Outstanding Shares | 189,437,438 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -11.66 |
|---|---|
| PEG | 137.94 |
| Price to Sales | 32.97 |
| Price to Book Ratio | 8.24 |
| Enterprise Value to Revenue | 25.81 |
| Enterprise Value to EBIT | -11.62 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About BridgeBio Pharma Inc
CEO: Neil Kumar